Matthew Carpenter to Cannabinoids
This is a "connection" page, showing publications Matthew Carpenter has written about Cannabinoids.
Connection Strength
0.063
-
A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
Score: 0.024
-
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010 Mar-Apr; 19(2):187-9.
Score: 0.020
-
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
Score: 0.019